Dimension scores are derived from public data and fields; weighted into the composite. Reference only.
DEA Compliance Consulting is not a cybersecurity vendor in the traditional sense. It is a regulatory compliance consulting service for organizations registered with the U.S. DEA. Its goal is to help pharmacies, practitioners, narcotic treatment programs, and distributors understand and meet DEA requirements for controlled substances, reducing the risk of civil or administrative penalties, registration revocation, and related issues.
In terms of “protection type,” it is closer to compliance risk protection. Through comprehensive compliance audits, gap analysis, remediation recommendations, employee training, and guidance on identifying suspicious orders, it helps uncover issues such as incomplete recordkeeping, improper handling of controlled substances, unrecorded losses or theft, and insufficient suspicious order monitoring. Its delivery model is consulting and manual audit services; the main content does not indicate SaaS, on-premise systems, automated scanning, or cybersecurity monitoring capabilities. For management and alerts, it only mentions helping identify “red flags” and suspicious orders, without describing an automated alerting platform. Integration capabilities, APIs, and connections with SIEM or GRC systems are not disclosed.
The website does not publicly disclose its pricing model, price range, payment methods, or contract terms; users need to contact the company for consultation. In terms of compliance certifications, the text does not mention SOC 2, ISO 27001, HIPAA, or other third-party certifications. Its credibility mainly comes from the team’s background: members include retired DEA Diversion Investigators, and the company claims more than 30 years of inspection experience across pharmacies, narcotic treatment programs, practitioners, and distributors.
Its strengths are clear positioning and a focus on DEA-registered entities. The service covers audits, remediation, training, and preparation for DEA inspections, with strong industry relevance around the regulatory details of controlled substances. The drawbacks are also obvious: there is little information about any productized platform, and it cannot replace cybersecurity protection, log monitoring, vulnerability management, or data security tools. Pricing, delivery process, support SLA, and case studies are also insufficiently detailed.
It is suitable for organizations handling controlled substances under the U.S. DEA regulatory framework, especially those concerned about surprise inspections, recordkeeping deficiencies, or inadequate suspicious order reporting. For companies based in mainland China, its direct applicability is limited unless they are involved in U.S. DEA-registered operations. The source text does not allow us to determine its accessibility from China, and payment methods are not disclosed. If a domestic alternative is needed, organizations should usually look for local pharmaceutical regulatory compliance, GxP, controlled drug management, or specialized regulatory consulting providers rather than cybersecurity vendors.
⚠ This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on deacompliance.consulting official site.
deacompliance.consulting is an United States Legal & Tax provider. TG4G tracks its product information, an overall rating of 6.0/10, and a China-accessibility score of Limited (proxy recommended). Click "Visit Official Site" to reach deacompliance.consulting directly.